NEW YORK (GenomeWeb) – Researches from Tufts Medical Center and other institutions working with Illumina have published a new study in which they identified a total of 10 cases of maternal cancer in women who received a discordant or false-positive result after Illumina's non-invasive prenatal testing.
The data, which appeared yesterday in JAMA, represent a retrospective analysis of over 125,000 samples tested by Illumina between February 2012 and September 2014.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
